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Abstract
Functional reconstitution of the cholesterol-dependent cytolysin vaginolysin (VLY) from Gardnerella vaginalis into
artificial tethered bilayer membranes (tBLMs) has been accomplished. The reconstitution of VLY was followed in real-
time by electrochemical impedance spectroscopy (EIS). Changes of the EIS parameters of the tBLMs upon exposure
to VLY solutions were consistent with the formation of water-filled pores in the membranes. It was found that
reconstitution of VLY is a strictly cholesterol-dependent, irreversible process. At a constant cholesterol concentration
reconstitution of VLY occurred in a concentration-dependent manner, thus allowing the monitoring of VLY
concentration and activity in vitro and opening possibilities for tBLM utilization in bioanalysis. EIS methodology
allowed us to detect VLY down to 0.5 nM (28 ng/mL) concentration. Inactivation of VLY by certain amino acid
substitutions led to noticeably lesser tBLM damage. Pre-incubation of VLY with the neutralizing monoclonal antibody
9B4 inactivated the VLY membrane damage in a concentration-dependent manner, while the non-neutralizing
antibody 21A5 exhibited no effect. These findings demonstrate the biological relevance of the interaction between
VLY and the tBLM. The membrane-damaging interaction between VLY and tBLM was observed in the absence of the
human CD59 receptor, known to strongly facilitate the hemolytic activity of VLY. Taken together, our study
demonstrates the applicability of tBLMs as a bioanalytical platform for the detection of the activity of VLY and
possibly other cholesterol-dependent cytolysins.
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Introduction
Cholesterol-dependent cytolysins (CDCs) comprise a class
of structurally related bacterial pore-forming toxins. CDCs are
produced by many gram-positive pathogens [1] and have been
considered as virulence factors of bacteria contributing to
bacterial invasion and infection [2-4]. In addition, CDCs have
been recently identified in non-pathogenic gram-negative
species [5]. Vaginolysin (VLY), the toxin of CDC family, is
secreted by Gardnerella vaginalis [6]. G. vaginalis has been
identified as the prevailing inhabitant of the vaginal tract of
women diagnosed with bacterial vaginosis (BV) [7,8]. BV, a
disease characterized by malodorous vaginal discharge, is
linked with infertility, adverse pregnancy outcomes, post-
surgery infections and may increase the risk of acquiring
sexually transmitted diseases [8,9]. Despite a strong correlation
between the abundance of G. vaginalis and the BV state, the
role of G. vaginalis was considered elusive [10]. However,
recent findings on a link between a structured polymicrobial G.
vaginalis biofilm covering the endometrium and fetal loss [11] is
compelling evidence for the active role of G. vaginalis in the
degradation of the vaginal mucus [12] and the significance of
this particular bacterium in BV. VLY is now considered as a
well-recognized virulence factor of G. vaginalis [6,13]. In
addition, recent data have demonstrated that differing VLY
production levels between G. vaginalis strains may correlate
with the phenotypes of BV [14]. Consequently, fast analytical
detection of VLY and its activity, is an important issue in the
assessment of the nature of the infection and could facilitate
the improvement in existing methods of BV diagnosis.
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Commonly, CDCs activity is determined by in vitro assays
using either red blood cells or cell lines such as HeLa [6,13].
Alternatively, the amount of CDCs produced by bacteria can be
determined by immunoassays if the appropriate antibodies are
available [13-16].
We aim at developing an alternative bioanalytical technique
that would significantly simplify and speed up the measurement
of the activity of the toxin so that analysis may be performed
within several minutes. In our approach, we utilize the property
of VLY as a member of a CDC group of toxins to bind to
cholesterol-containing membranes of target cells. CDC binding
leads to pore-formation that triggers cell lysis and death. The
formation of defects or water-filled pores in artificial tethered
bilayer membranes (tBLMs) [17,18] can be easily sensed and
followed, in real-time, by electrochemical techniques, in
particular, by electrochemical impedance spectroscopy (EIS)
[19-21] and opens the possibility of tBLM use in bioanalytical
applications.
Recently, tBLMs in combination with EIS data was applied to
the detection of α-hemolysin (αHL) in protein solutions [20] and
cell cultures [22,23]. Reconstitution of αHL into phospholipid
bilayers has no strict requirement for cholesterol occurring via
direct interaction of the protein monomer with the membrane
followed by subsequent oligomerization into a heptameric pore
[24].
The detailed mechanism of VLY binding is still unknown. It
was shown that VLY as well as intermedilysin from
Streptococcus intermedius and lectinolysin from Streptococcus
mitis use human CD59 as their receptor rather than cholesterol
to bind to a membrane [6,25,26]. CD59 is a glycosyl-
phosphatidylinositol (GPI)-anchored membrane protein that
blocks the formation of the complement membrane attack
complex (MAC) by binding complement proteins C8α and C9
[27]. It is presumed that the requirement of CD59 in membrane
binding results in the specificity of VLY to human cells as
mouse erythrocytes were 200-fold less susceptible to its
hemolytic activity [6,13]. Even though the role of CD59 receptor
in VLY toxicity is well-established, it is not yet clear if VLY is
capable of producing membrane pores in the absence of this
receptor. The strict requirement for both CD59 and cholesterol
would make artificial bilayer-based bioanalytical systems more
complex and possibly less attractive from a practical point of
view. In distinct contrast, the possibility of detecting VLY
activity on already well-characterized tBLMs containing no
CD59 could lead to the development of fast bioanalytical
systems [28].
The objective of this paper was to investigate the
reconstitution of VLY in the absence of CD59 into tBLMs and
verify their applicability in sensing the bioactivity of CDCs.
Dioleoylphosphocholine tBLMs with variable amount of
cholesterol have been described and characterized earlier [29].
In the current study we demonstrate that both recombinant and
pathogen-produced VLY, but not inactivated VLY mutants
specifically inflict dielectric damage to tBLMs, thus opening a
gateway for the development of tBLM-based bioanalytical
systems for the detection of VLY activity.
Materials and Methods
Gold-coated glass slides
Gold-coated glass slides for tBLMs were made in a PVD75
(Lesker, UK) vacuum system using 50.8 mm metal sputtering
targets. Typically 50±5 nm thick gold films, deposited atop a
previously sputtered layer of Cr (2 nm) to ensure adhesion of
the gold film to the glass substrate, were used throughout the
work. Magnetron deposition parameters for gold were as
follows: sputtering voltage ≈350 V, sputtering pressure of an
argon ≈5 mbar; deposition rate ≈0.4 nm/s. High purity (99.9999
%) argon was used as sputtering gas. Before coating, the glass
slides were cleaned by i) rinsing with Micro 80 ® solution
(Sigma-Aldrich, Germany) and pure water (Milli-Q Plus, USA) ,
and ii) chemically cleaning in Nochromix ® solution (Sigma-
Aldrich, Germany) for 20 min. Both steps were followed by
rinsing with copious amount of pure water, filtered by Millex-
FH® filter with 0.45 μm pores (Millipore, USA), blow-dried in a
stream of 99.99% nitrogen (AGA, Sweden), and immediately
transferred into the vacuum chamber. Glass slides (25x75 mm)
were from various vendors, including Fischer Scientific.
Preparation of tethered bilayer membranes
Tethered (phospho) lipid bilayer membranes (tBLMs) were
prepared on the gold-coated glass slides by the solvent
exchange method [17,30] as described earlier [28]. Briefly, the
freshly gold-coated glass slides were immersed overnight,
typically 12-18 h, in a 0.2 mM solution of the tether WC14 (20-
tetradecyloxy-3,6,9,12,15,18,22-heptaoxahexatricontane-1-
thiol, synthesized in-house), and β-mercaptoethanol (Sigma-
Aldrich, St.Louis, MO) mixed at molar ratio 3:7 in ethanol (96.3
vol.% ) to form mixed self-assembled monolayers (SAMs).
After incubation, the slides were washed with 20-30 ml of pure
ethanol (96.3%) and dried in a nitrogen stream. After the
formation of the tethering SAMs, the slides were used
immediately. However, we established that they could be
stored for up to 10 days without losing their ability to form
tBLMs. The tether-functionalized gold films were assembled
into an electrochemical setup with 6 independent 250-300 µL
vials. The bottom of each vial was a patch of the tether-
functionalized gold layer and is exposed to the subsequent
solutions. The picture of the setup used in this work can be
found in the material of ref [29].
.The tBLMs were formed by putting 50 µL of an ethanolic
phospholipid solution into the vial, and then rapidly exchanging
it (using a syringe) with 15-20 mL of aqueous phosphate buffer
(0.1 M NaCl, 0.01 NaH2PO4 adjusted to pH=7.2±0.1 with
NaOH). Purified Milli-Q Plius (Millipore, USA) water was used
for all buffers. The membranes were equilibrated with the
working phosphate buffer for at least 30 min and only those
tBLM samples exhibiting stable parameters were used.
Because water-soluble ethanol was used in the preparation of
the tBLMs, any residual amount of ethanol in the membranes is
reduced to undetectable levels by copious flushing the
measurement cell with buffer. The phospholipids – 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) and 1,2-diphytanoyl-sn-
glycero-3-phosphocholine (DPhyPC) – as well as the
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cholesterol were all purchased from Avanti Polar Lipids
(Alabaster, AL) in powder form and used as received.
Electrochemical impedance measurements
Electrochemical impedance was measured using a universal
electrochemical workstation Zennium (Zahner, Kronach,
Germany) in the frequency range between 0.1 Hz and 100 kHz,
with 10 logarithmically distributed measurement points per
decade. The working surface area exposed to the solution was
0.32 cm2. The EIS data is presented normalized to the
geometric surface area as calculated from the roughness factor
of the magnetron sputtered gold films – estimated from the
oxidation/oxide stripping charge of the gold to vary from 1.35 to
1.40. A saturated silver-silver chloride (Ag/AgCl/NaCl (aq. sat.))
microelectrode (M-401F, Microelectrodes, Bedford, NH) was
used as reference, which has the potential +196 mV vs.
standard hydrogen electrode. All potentials are referred vs. the
reference electrode. The auxiliary electrode was a platinum
wire (99.99% purity, Aldrich; diameter = 0.25 mm) coiled
around the barrel of the reference electrode. Measurements
were carried out with 10 mV alternating current at 0 V bias
versus the reference electrode in aerated solutions. The
admittance of the tBLMs was determined from the
electrochemical impedance spectra (see Figure S2 in File S1
for details). Average admittance values and standard errors
were obtained from at least 3 independent measurements, on
different tBLMs.
Preparation of liposomes
Vesicles were prepared using 0.001 mol/L chloroform
solutions of cholesterol/DOPC at a molar ratio of 40/60, which
approximately mimics biological membrane compositions. A
lipid film was prepared by evaporating 1 mL of the chloroform
solution in a gentle stream of nitrogen followed by vacuum-
drying for 1-2 h. The lipid film was re-dissolved in 1 mL of
pentane and dried overnight. The film was hydrated by adding
1 mL of working buffer, 0.1 mol/L NaCl, 0.5 x 10-3 mol/L
NaH2PO4 (pH 7.4), sonicated for 60 min, and incubated with
occasional vortexing, as needed until the lipid film was no
longer visible. The lipid preparation was then extruded 21 times
through a 100 nm polycarbonate membrane (Avanti Polar
Lipids, Alabaster, AL). Vesicle size (≈50-100 nm) was
determined by dynamic light scattering as described earlier
[31].
Generation of recombinant VLY
Recombinant N-terminally-hexahistidine-tagged VLY (rVLY)
lacking the putative signal sequence [amino acids (aa) 1-31]
was expressed and purified as described previously [13].
Generation of rVLY mutants
All rVLY mutants were generated using pUC57 plasmid
carrying the VLY coding gene lacking 1-31 aa as the template
for PCR-mediated, site-directed mutagenesis targeted to the
whole plasmid. All PCR generated VLY-encoding sequences
were confirmed by DNA sequence analysis. Three aa
substitutions (A162V; R163V; A162E) targeted the motif
located in β1-strand of domain 3. The double mutant
(T474G•L475G) was generated according to Farrand et al. [32].
The VLY mutants were cloned into pET28a(+) vector (Merck,
Darmstadt, Germany) for construction of hexahistidine-tagged
proteins, expressed and purified as described previously [13].
Circular dichroism (CD)
CD spectra were recorded on a J-815 CD Spectrometer
(Jasco) at 25°C over the wavelength interval 190-300 nm at a
scan speed of 50 nm/min and averaged from three scans with
all protein concentrations at 0.2 mg/mL in 20 mM sodium
acetate buffer (pH 5.5). A reference spectrum of the sodium
acetate buffer only was recorded and subtracted from the
sample spectra. The CD of the rVLY and its mutants were
expressed as the mean of the residue ellipticity (MRE).
Determination of rVLY hemolytic activity
Hemolytic activity of each rVLY mutant and rVLY was
determined on human erythrocytes as described previously
[13]. The HD50 was defined as the concentration of rVLY
required to lyse 50% of human erythrocytes and was
determined by hemolytic assay performed in triplicate.
Supernatants of G. vaginalis cultures
The supernatants of G. vaginalis strains (GV32, GV33,
GV34, GV35 and GV36) used in this study were described
previously [14]. The VLY secretion level determined by a
sandwich enzyme-linked immunoassay (ELISA) of strains
GV32 and GV36 was considered as moderate (0.4-0.8 µg/mL),
strains GV33 and GV34 produced low levels of VLY (<0.4
µg/mL) and the level of VLY in the culture of GV35 was not-
detectable [14].
Monoclonal antibodies
The monoclonal antibodies (MAbs) against rVLY used in this
study were described previously [13]. For the inhibition of rVLY
activity, MAb 9B4 with the most potent neutralizing activity (IC50
= 6.7x10-11) and MAb 10A6 with a moderate neutralizing activity
(IC50 = 3.6x10-9) were employed. As a negative control for rVLY
inhibition experiments, the non-neutralizing MAb 21A5 against
rVLY and an irrelevant MAb of IgG1 subtype against measles
nucleocapsid protein (clone 22G2) were used [33].
Enzyme-linked immunosorbent assay (ELISA)
The reactivities of the MAbs with mutant forms of VLY were
tested by an indirect ELISA as reported previously for rVLY
[13]. Briefly, microtiter plates were coated with purified mutant
rVLY by adding 100 μl of a rVLY solution (5 μg/mL) to a coating
buffer (50 mM Na2CO3, pH 9.5) solution and incubated
overnight at +4°C. The plates were blocked with 1% bovine
serum albumin (BSA) in phosphate buffer system (PBS) and
then incubated with the MAbs added in triplicate at
concentrations ranging from 3.7x10-11 M to 75x10-9 M. After
washing, the plates were incubated with human recombinant
protein (HRP)-labeled goat anti-mouse immunoglobulin G
[(IgG); BioRad] diluted 1:2000 in PBS for 1 h at RT. After
washing, the enzymatic reaction was developed with 3,3',5,5'-
Reconstitution of Vaginolysin into Bilayers
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tetramethylbenzidine (TMB) substrate (Sigma) and stopped by
adding 1 M H2SO4. The optical density was measured at 450
nm (OD450) in a microtiter plate reader (Tecan). For each MAb
concentration, the mean OD450 value (±SD) was calculated
from triplicates.
Ethics statement
The use of human erythrocytes from healthy adult volunteer
followed written informed consent was approved by the Council
of the Institute of Biotechnology (Protocol of 30/03/2010, no. 3
with the extension for four years).
Results
Electrochemical impedance of tBLMs is affected by
rVLY
Injection of rVLY into the buffer solution in contact with
tBLMs triggers changes in the electrochemical impedance (EI)
spectra of those tBLMs that contain cholesterol (Figure 1). In
the absence of rVLY, Bode plots of the EI magnitude |Z| vs.
frequency, exhibit an inflection centered around 0.2-0.3 Hz
(Figure 1A), that coincides, on the frequency scale (Figure 1B),
with the minimum of the negative of the impedance phase, -
arg Z. Introduction of rVLY lowers |Z|, in the low frequency
range, and triggers a shift of the phase minimum towards
higher frequencies. Such features were observed for other
pore-forming toxins such as αHL [20,34]. The extent of the EI
spectral changes was found to be time dependent (data not
shown). To elucidate the concentration dependent nature of the
rVLY-membrane interaction, all curves in Figure 1 were
recorded 30 min after injection. It is obvious that rVLY affects
the EI spectra of the tBLMs in a concentration dependent
manner. In control experiments, with no rVLY present, the
tBLMs demonstrated EI parameter stability qualitatively and
quantitatively. Additional control experiments using unrelated
protein BSA in the concentration range from 10 to 100 nM
indicated no effect on the experimental EI curves (see Figure
S3 in File S2). Thus, the EI spectral changes seen in Figure 1
are unambiguously due to the presence of the added rVLY.
Noteworthy, the EI spectral changes triggered by the addition
of rVLY aliquots were irreversible, i.e. were not reversed by
flushing the vials with rVLY-free buffer. Similar behavior is
typically observed for β-barrel, pore-forming toxins [24,35,36].
To quantify the effect of rVLY on the electrical parameters of
the tBLMs, as suggested by Cornell et al. [17,30,37,38], |Z| was
measured at the frequency point, fmin, at which the minimum of
the negative of impedance phase is observed. Since the extent
of membrane damage and defectiveness could be more
conveniently related to the conductance of tBLMs at fmin,
hereinafter, the admittance, |Yfmin|= |Zfmin|-1, is used to
characterize the interaction between rVLY and the tBLMs.
More details on the methodology are presented in the Figure
S1 in File S1 and File S1.
rVLY-induced damage of tBLMs is dependent on
cholesterol concentration
Because rVLY belongs to a class of CDC, one may expect
that the amount of cholesterol will affect the damage inflicted
by rVLY to the membrane integrity. Such an effect is clearly
demonstrated by the data in Figure 2. At two different protein
concentrations (2.8 and 5.4 nM) the rVLY-induced admittance,
|Yfmin|, depends on the cholesterol concentration in the DOPC
tBLMs. At low cholesterol content (<10%), a marginal increase
of the admittance of the tBLMs is observed. More than a 100-
fold increase was detected at higher cholesterol concentrations
(>20%) clearly indicating cholesterol is an essential component
for activating the ability of rVLY to inflict damage to tBLMs, i.e.
artificial phospholipid membranes. One possible cause for the
inflicted damage is a cholesterol-induced change in the
dielectric constant of the tBLM. It is well known that cholesterol
lowers the dielectric constant within bilayer hydrophobic sheet
[29]. To test for this, we modified the composition of the tBLMs
using diphytanoylphosphocholine (DPhyPC) instead of DOPC.
Although DPhyPC tBLMs exhibit significantly lower dielectric
constants as compared to DOPC tBLMs [39], addition of rVLY
resulted in no changes of the admittance of the cholesterol-free
DPhyPC tBLMs (data not shown). These results eliminate
dielectric constant factors as the cause the rVLY damage.
Mutant rVLY variants with reduced hemolytic activity
To show that the observed effects presented in Figure 1 and
Figure 2 are specific to rVLY and not related to some non-
specific interaction of the peptide chain with the tBLM we used
engineered mutant variants of rVLY with altered hemolytic
activity (Figure S4). The rVLY mutants had amino acid (aa)
substitutions in the VAARMQYD (aa 160-167) motif situated in
the β1-strand of the VLY domain 3 (D3). Selection of the motif
was based on previous publications reporting that the β1 and
the β4 in D3 constitute the interface for monomer-monomer
interaction in the perfringolysin oligomer [40]. The expression
level in E. coli of each rVLY mutant was approximately in the
same range as that of rVLY and the mutants were purified from
the soluble fraction of E. coli lysate (data not shown). The
hemolytic activity of the VLY mutants was determined using
human erythrocytes. The aa substitutions altered the hemolytic
activity of the rVLY mutants to a different extent (Table 1). The
substitution of Ala-162 to the charged aa Glu (A162E) gave a
non-hemolytic phenotype, while the substitutions Ala-162 to Val
(A162V) and the Arg-163 to Val (R163V) decreased rVLY
activity about 15 fold and four-fold, respectively.
The double rVLY mutant was generated in which Thr-474
and Leu-475 were converted to glycines based on the previous
report demonstrating an essential role of these aa residues for
cholesterol binding [32]. The substitution of the Thr-Leu pair
with Gly’s (T474G•L475G) resulted in a fully non-hemolytic
rVLY phenotype (Table 1). In addition, the double mutant
T474G•L475G did not show detectable binding to cholesterol-
rich liposomes (data not shown).
To prove that the mutations did not alter the structure of
rVLY, the activities of all generated rVLY mutants were tested
with a panel of VLY-specific MAbs [13] and found to be reactive
with the MAbs to the same extent as rVLY both by ELISA
Reconstitution of Vaginolysin into Bilayers
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Figure 1.  Impedance Bode plots of DOPC/CHOL40% tBLMs upon exposure to rVLY solutions of different
concentrations.  Exposure time 30 min. (A) Impedance magnitude. (B) Impedance phase.
doi: 10.1371/journal.pone.0082536.g001
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(Figure S5) and Western blot (data not shown). We also
performed circular dichroism (CD) measurements of rVLY and
the rVLY mutants. The CD spectra of the mutants were not
discrepant from that of rVLY (Figure S6).
Inactivated forms of rVLY mutants do not affect the
electric properties of the tBLMs
As the above data demonstrate, certain aa substitutions in
the β1 strand of D3 almost fully inactivated hemolytic activity of
rVLY (Table 1). To show whether the rVLY-tBLM interaction
and the subsequent inflicted dielectric damage to the tBLMs
correlate with the hemolytic activity of rVLY in vitro, we carried
out parallel experiments with the rVLY mutants A162V, A162E
and T474G•L475G on same-batch tBLMs. Data presented in
Figure 3 show a significant, almost 70-fold increase in the
admittance for the rVLY-tBLM interaction as compared to that
for the partly inactive A165V mutant, in the same concentration
range. Under the identical experimental conditions, the non-
hemolytic mutants A162E (Figure 3) and T474G•L475G (data
Figure 2.  Cholesterol concentration-dependent tBLM admittance change triggered by rVLY.  EIS recorded 30 min after the
injection of rVLY. Incubation time 30 min.
doi: 10.1371/journal.pone.0082536.g002
Table 1. Hemolytic activity of rVLY mutants.
rVLY variants HD50 (pM) rVLY activity (%)
rVLY 10±1 100
A162V 157±5 6
R163V 39±2 25
A162E >2000 <0.01
T474G•L475G >2000 <0.01
doi: 10.1371/journal.pone.0082536.t001
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not shown) did not exhibit any effect on the insulating
properties of the tBLMs.
Neutralizing monoclonal antibodies against rVLY
inhibit deterioration of electrical insulation of tBLMs
Neutralizing antibodies reduce the hemolytic activity of
cytolysins. Recently, a series of monoclonal antibodies agaist
rVLY with different inhibitory potencies was described [13]. We
demonstrated that the neutralizing MAb 9B4 reduced the
hemolytic activity of rVLYand its mutants in a dose-dependent
manner while the non-neutralizing MAb 21A5 did not effect the
hemolytic activity of rVLY and its derivatives (Figure S7).
Neither MAb impacted the activity of non-hemolytic mutants
A162E and T474G•L475G (Figure S7B). To test if
preincubation of rVLY with the neutralizing MAb 9B4 affects its
membrane damaging activity we carried out a series of
experiments with different rVLY/MAb ratios (Figure 4). The
control experiment included the preincubation of rVLY with
non-neutralizing MAb 21A5.
Clearly preincubation with the neutralizing MAb 9B4
inactivates the membrane-damaging activity of rVLY in a
concentration-dependent manner. The non-neutralizing MAb
21A5 does not inhibit rVLY hemolytic activity in vitro [13] nor on
the tBLM-damaging activity of rVLY.
Tethered bilayer membranes act as real time sensors
for VLY production in bacterial cultures
To demonstrate the applicability of the tBLMs for sensing
VLY in real biological media we investigated how culture
supernatants from two strains of G. vaginalis affect the
admittance. The VLY production levels of different G. vaginalis
strains were determined by ELISA [14]. The bacterial
supernatant from strain GV35 with undetectable level of VLY
was found to be inactive towards the tBLMs (Figure 5). In
contrast, the supernatant from the G. vaginalis strain GV36
Figure 3.  Admittance change of DOPC/CHOL40% tBLMs by different variants of VLY: rVLY (black bars), rVLY mutants
A162E (white bars) and A162V (grey bars).  Exposure time 30 min.
doi: 10.1371/journal.pone.0082536.g003
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with a high level of VLY exhibited a significant effect on the
conductance of the tBLMs (Figure 5). Data presented in Figure
5 clearly demonstrate the correlation of an increase of
membrane-damaging activity and growth time of bacterial
culture, which is consistent with VLY accumulation in G.
vaginalis cultures. VLY activity towards the tBLMs increases
sharply (24 h) then decreases thereafter (48 hr). Thus, VLY-
induced admittance of tBLM fully reproduces the VLY
production pattern measured by ELISA.
Discussion
tBLMs may be utilized as bioanalytical devices for toxin
sensing in cases where physical responses in a biologically
relevant process are generated upon interaction with proteins
[22]. Our data show that our rVLY preparations affect physical
properties, in particular, the impairment of dielectric/insulating
properties of tBLMs in a concentration-dependent manner
(Figure 1). The decrease of the impedance magnitude
(increase of admittance) and the shift of the negative of
impedance phase minimum in the frequency range from 0.1 to
100 Hz (Figure 1), is most likely the result of the formation of a
pore in the bilayer by the VLY oligomers, as predicted
theoretically [19]. Nevertheless, variations similar to ones
observed in Figure 1 may also be triggered by a non-specific
interactions between peptide chains and the hydrophobic core
of a bilayer. In other words, EIS features such as seen in
Figure 1A and 1B may be observed without functional
reconstitution of VLY and pore formation but simply due to
protein adsorption to a membrane surface [41] or an insertion
of protein that leads to an increase in the dielectric constant, a
decrease in the dielectric barrier, and consequently in a loss of
the ability of the phoholipid bilayer to prevent uncontrolable ion
flow through the membrane [39]. For this reason we needed to
establish that the changes triggered by the rVLY in tBLMs are
biologically relevant.
Biological relevance of the interaction between rVLY and the
tBLMs could be verified by comparing the effects in tBLMs and
hemolytic activity measured in cell culture. It is believed that
pore formation in cell membrane is the primary reason for the
cytotoxicity of VLY. Correlation of EIS features that are typical
in the presence of water-filled defects with hemolytic activity
would indirectly prove the existence of such pores and provide
the biologically-sound basis for sensing and detection of this
virulence factor by tBLM-based sensors.
A straightforward way to test for biological relevance of
protein-membrane interactions is to introduce mutations into
the protein that would alter its biological activity (e.g. hemolytic
Figure 4.  rVLY-induced admittance change of DOPC/CHOL 40% tBLMs after 30 min preincubation with different MAbs:
neutralizing MAb 9B4 (black bars), moderate neutralizing MAb 10A6 (white bars) and non-neutralizing MAb 21A5 (grey
bars).  Exposure of the tBLMs to rVLY time 30 min. rVLY/MAb molar ratios indicated below the abscissa.
doi: 10.1371/journal.pone.0082536.g004
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activity) yet minimaly change the protein composition and
structure, and, consequently, any presumed non-specific
interaction between the protein and the membrane. Variation of
the amino acid sequence in the rVLY region presumably
involved in oligomerization [40] and, consequently, for the
specific property of VLY to oligomerize into a pore strongly
reduces the hemolytic activity of rVLY for the A162E and
T474G•L475G substitutions (Table 1). The EIS spectra of the
tBLMs exposed to solutions (≈1 nM) of these mutants indicated
no activity (data not shown), in agreement with the in vitro
hemolytic activity data. The A162V and R163V substitutions
supress hemolytic activity only partly (Table 1). Again, the EIS
data follows the same pattern. The admittance increase is less
in the A162V mutant compared to that for rVLY. At lower rVLY
concentrations (<1.1 nM) the hemolytic activity decrease and
the admittance increase match almost quantitatively, i.e. for the
A162V mutant (HD50 almost 16-fold higher while the toxin-
induced admittance change is ≈10-15 times lower). At higher
concentrations, the A162V-induced admitance chanel is 3 to 10
times less prononced relative to rVLY (Figure 3, compare black
and grey bars). The data with the mutants suggest that
membrane changes induced by rVLY match the biological
activity of the toxin, strongly supporting the hypothesis that the
EIS variations indicate protein insertion and pore-formation in
the artificial membrane. Importantly, the experiments with the
rVLY mutants not only prove the biological relevance of the
tBLM EIS measurements they also confirm the ability of rVLY
and its partially inactivated variants to bind and form protein
pores in membranes in the abscence of CD59.
Another confirmation of the biological relevance of a tBLM
response to VLY can be obtained using neutralizing and non-
neutralizing monoclonal antibodies (Figure 4). As expected,
MAb 9B4, which fully neutralizes the cytolytic activity of rVLY
[13] removed any effect of rVLY on the tBLM insulating
properties. The action of the MAb 9B4 is concentration-
dependent (Figure 4) proving that antibody binding to a rVLY is
inhibiting electrochemical changes in the tBLMs. Within the
margin of error, no changes in the tBLM admittance can be
detected if rVLY is preincubated with MAb 9B4 at the protein/
antibody ratio larger than 1:5. Another antibody MAb 10A6,
which exhibits moderate neutralizing activity in hemolytic tests
[13] inhibited the tBLM dielectric damage to a lesser extent
(Figure 4). Finally, pre-incubation of rVLY with non-neutralizing
MAb 21A5 showed no inhibitory effect in the membrane
Figure 5.  Quantification of VLY production in two G. vaginalis cultures by EIS and ELISA.  Variation of the admittance of
DOPC/CHOL40% tBLMs upon exposure to VLY in supernatants from two different strains of G. vaginalis (bars). VLY concentration
(line) measured by ELISA. Exposure time of tBLM 30 min. Cultivation time of G. vaginalis is indicated under the abscissa.
doi: 10.1371/journal.pone.0082536.g005
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admittance change (Figure 4). Taken together, the
neutralization experiments rule out the possibility of rVLY-tBLM
non-specific interactions as a cause of the EIS changes (Figure
1).
Recent studies show that the amount of VLY produced by
different G. vaginalis clinical isolates cultivated in vitro can be
detected by immunoassays based on either polyclonal or
monoclonal VLY-specific antibodies [14,16] and that G.
vaginalis strains differed in VLY production levels [14].
Correlation of the level of produced toxin with electrochemical
response would also confirm that the VLY-tBLM interactions
are biologically relevant as well as demonstrate the applicability
of the tBLM sensors for monitoring toxin production in media.
The amount of VLY produced by different G. vaginalis strains
and the EIS response obtained on the tBLMs are completely
analogous (Figure 5). With the bacterial strain GV35, which did
not produce detectable amounts of VLY [14], no variation of the
EIS and the admittance of the tBLM was observed. A different
EIS response was observed with the supernatants from GV36
strain that demonstrated production of significant amouts of
VLY, up to 10-12 nM as determined by ELISA (Figure 5, line
curve) and the admittance of the cholesterol-containing tBLMs
closely followed the ELISA data. Interestingly, even such subtle
details as the slight decrease of VLY concentration in the
media after 24 hrs of cultivation, is reproduced by the variation
of the admittance of tBLMs proving the applicability of the tBLM
sensors in bioanalytical applications to detect both the activity
and amout of produced VLY in real media.
Our data strongly suggests that VLY is capable of membrane
binding and forming pore-like defects in the absence of the
human CD59 receptor. This finding is quite unexpected
because there exists evidence to the contrary [6,25] and forms
the basis of the conclusion that CD59 is a principle mediator of
VLY pore-formation and toxicity, along with cholesterol. We
show uniquivically that the binding of VLY to a bilayer occurs
without mediation of human CD59, while the requirement for
the cholesterol is strictly unconditional. We performed some
numerical estimates of the density of defects (presumably,
pores) produced by VLY in the tBLMs, following the EIS
formalism developed earlier [19] to explain this seeming
contradiction with the biological data [6,14].
The defect density in pristine tBLMs estimated from the EIS
Bode spectra is less than 0.01 µm-2 [phase minimum at fmin≈0.4
Hz (Figure 1B ); see formula eq. (34) in ref. 17]. However, the
accuracy of such estimates are dependent on knowing the
defect radius. Because of a lack of structural data on VLY we
can make only a rough estimate of the maximum density of
protein pores. Favourably, the theory predicts a weak
dependence of the position of -arg Z vs. frequency on defect
size [19]. Assuming the radius of the VLY pore falls into a
rather wide interval from 1 to 10 nm, we obtain maximal
densities of defects that are summarized in Table 2. Maximal
densities are obtained assuming a pore radius of 1 nm and
increasing the pore radius to 10 nm results in a decrease of the
upper limits by only 1.58. These theoretical estimates show
that, even in the absence of CD59, VLY is capable of
producing significant pore densities in tBLMs (Table 2).
However, one needs to take into account that the
concentrations at which the EIS experiments were carried out
are well above the physiological concentrations of CDCs in
natural media (see e.g. ref [42]). For human erythrocytes that
contain CD59 the HD50 for rVLY is observed at 0.01 nM (Table
1), which is at least a factor of 50 lower than any reliably
detectable activity of rVLY, as measured in this work on CD59-
free tBLMs (at 0.5 nM rVLY). This suggests that in the absence
of CD59 relatively large concentrations of VLY are required for
reconstitution into functional oligomeric pores, in good
agreement with earlier rVLY toxicity tests obtained utilizing
mouse erythrocytes that lack human CD59. The HD50 for
mouse erythrocytes is approximately 200-fold higher than that
for human erythrocytes [23]. As a result we conclude that both
the biological toxicity data and electrochemical data obtained in
this study are in good qualitative and quantitative agreement
and confirm functional reconstitution of VLY into model bilayer
membranes.
Assuming a model erythrocyte has the shape of an oblate
spheroid we can estimate the number of VLY-generated
defects. With an equatorial and an axial radius of a =3.5 µm
and c =1 µm, respectively, the surface area of such a
hypothetical erythrocyte is estimated to be ≈80 µm2 by the
following equation [43]:
Table 2. Estimates of defect density and number of pores per model erythrocyte.
rVLY concentration (nM) fmin (Hz) Density of pores in tBLM (µm-2) Number of pores per model erythrocyte
0 0.4 <0.02 n/a
0.12 0.3 <0.01 <1
0.25 0.3 <0.01 <1
0.5 1.4 <0.28 <22
1 4.2 <2 <180
1.5 8.1 <8 <650
3 55 <330 <2.6⋅104
doi: 10.1371/journal.pone.0082536.t002
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where the ellipticity parameter is defined as:
e= 1− c
2
a2  .
Taking into account the defect density data (Table 2, third
column) one may estimate the upper defect limit present on the
surface of hypothetical erythrocyte at a particular VLY
concentration (Table 2, fourth column). At low rVLY
concentrations, e.g. 0.25 nM (14 ng/mL), the number of defects
per erythrocyte is well below 1 and no hemolytic activity is
detected in mouse erythrocyte tests [23]. However, at 1 nM
VLY (≈60 ng/mL) almost 50% of mouse erythrocytes are lysed.
The EIS data in such a situation show up to 180 defects
present in the membrane for the above hypothetical
erythrocyte. This strongly suggests that in order to exert
noticeable hemolytic activity at least 100-200 toxin pores must
form on the surface of a cell.
Interestingly, our data shows that cholesterol plays a
decisive role in VLY pore formation. The absence of VLY
effects on the DPhyPC tBLMs indicates that the receptor type
of cholesterol-VLY interaction is responsible for VLY hemolytic
activity, not lowering of the dielectric constant as for αHL [29].
The absolute requirement for cholesterol is apparent from the
fact that even at rVLY concentrations as high as 5 nM (280
ng/mL, Figure 2) membrane damaging activity can be
essentially nullified by decreasing the tBLM cholesterol content
to 10%. We show in this work that CD59 is not an essential
factor for VLY hemolytic activity; however, it probably strongly
amplifies toxicity by either mediating monomer binding to the
phospholipid membrane or by accelerating membrane-
mediated oligomerization into the pore [44].
Conclusions
Artificial membranes tethered to a surface are biologically
relevant models for studying interactions between CDCs, in
particular, VLY with phospholipid membranes. They are
suitable and may be utilized as sensors for the detection of the
activity of VLY, and possibly other pore-forming CDCs.
Currently the sensitivity of our tBLM sensor, which is
determined solely by the residual specific admittance of the
membrane, is close to 0.5 nM (≈28 ng/mL). This concentration
is approximately 3 orders of a magnitude lower than that
achieved by optical techniques utilizing tBLMs (see e.g. surface
plasmon resonance spectroscopy methodology for the label-
free detection of cholera toxin [45]) and is comparable to the
sensitivity of amperometric electrochemical detection of
streptolysin from Streptococcus pyogenes [46,47]. The
sensitivity achieved in this work slightly surpasses that of
current ELISA methodologies, capable of detecting VLY down
to ≈100 ng/mL [14]. The limited data on the physiologic
concentrations of pore-forming toxins currently does not allow
the conclusion that the sensitivity achieved in this work is
sufficient to detect VLY in biological specimens such as vaginal
smears. Further development of tBLMs suitable for applications
in real clinical samples is in progress. Nevertheless, in
biotechnology and other indirect diagnostic applications, for
example, in cultivation media of pathogenic bacteria, the levels
of VLY could reach higher concentrations. The current work
demonstrates that data obtained using tBLM sensors match
well to that obtained using classical ELISA technology
indicating the tBLMs may be applicable for fast, automated,
real time detection of this toxin in cultivation media. The current
study provides unequivocal proof for the membrane-binding
and the pore-forming ability of VLY into a phospholipid
membrane in the absence of the human complement protein
CD59. While it is not clear what the molecular mechanism of
the CD59 activity is – increasing the amount of membrane
bound protein or accelerating oligomerization on the membrane
surface – it is evident that the introduction of CD59 into an
artificial tBLM architecture would appear to be a promising way
to further sensitize the detection of this and similar pathogens.
Supporting Information
File S1.  EIS methodology for measuring membrane
damage by the pore forming toxins. File contains the
following figures: Figure S1. (A) The electrical equivalent
circuit of an idealized phospholipid bilayer surrounded from two
sides by a conducting medium (electrolyte solution). R(sol)
represents the resistance of an electrolyte solution, C(mem)
represents the capacitance of a phospholipid bilayer
membrane. (B) The electrical equivalent circuit of a bilayer
membrane subject to a pore-forming toxin, which creates an
additional conductance pathway modeled by the impedance
Z(defect). Figure S2. Model Bode plots of the electrochemical
impedance spectra. (A) Impedance magnitude, and (B)
impedance phase vs. frequency curves. Blue curves represent
the impedance of an ideal, defect-free bilayer. Red and green
curves represent the impedance curves of the membranes
containing small (red) and large (green) number of defects.
Parameters for model curves are, as follows: R(sol) = 100 Ω,
C(mem) = 0.3 µF. Z(defect) was modeled by a series RC
element, which had the following values R = 106 Ω and
C=3·10-6 µF (red curves); R=104 Ω and C=3·10-6 µF (green
curves).
(PDF)
File S2.  Membrane damage: negative control with the
unrelated bovine serum albumin protein. File contains the
Figure S3. Impedance Bode plots of DOPC/CHOL 40% tBLMs
(black circles) upon exposure to 100 nM BSA solution (red
triangles). Exposure time 30 min. (A) Impedance magnitude,
(B) Impedance phase.
(PDF)
Figure S4.  Schematic representation of the VLY structure
and the positions of the aa mutations. The model of full-
length VLY domain structure is based on the homology with
ILY. Black area indicates the binding site for the neutralizing
MAb 9B4 [Ref. 13 in the main article]. rVLY lacked the putative
signal sequence (1-31 aa) (dashed area).
(TIF)
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Figure S5.  Binding of the MAbs 9B4 (A) and 21A5 (B) to
rVLY and its mutants determined by an indirect ELISA. The
MAbs were incubated at concentrations ranging from 3.7x10-11
M to 46x10-9 M on the microtiter plates coated with the
respective antigens. For each MAb concentration, the mean
OD450 values (+SD) calculated from triplicates are indicated.
Error bars represent 95% confidence intervals (CI) of mean
value where indicated.
(TIF)
Figure S6.  Circular dichroism (CD) spectra of rVLY and its
mutants in 20 mM sodium acetate buffer pH 5.5. MRE –
mean residue ellipticity.
(TIF)
Figure S7.  The effect of the MAbs 9B4 and 21A5 on the
hemolytic activity of rVLY and its mutant variants. The
effect of MAbs 9B4 and 21A5 on the hemolytic activity of rVLY
and rVLY mutant variants was tested by addition of human
erythrocyte suspension to (A) rVLY (5 ng/mL) pre-incubated
with either the neutralizing MAb 9B4 [Pleckaityte et al., 2011] or
non-neutralizing MAb 21A5 at concentrations ranging from
6.7x10-11 to 0.4x10-9 M; rVLY mutant R163V (10 ng/mL) pre-
incubated with either 9B4 or 21A5 MAb at concentrations
ranging from 6.7x10-11 M to 0.4x10-9 M; (B) rVLY mutant A162V
(30 ng/mL) pre-incubated with either 9B4 or 21A5 MAb at
concentrations ranging from 1x10-9 M to 6x10-9M; rVLY mutant
A162E (750 ng/mL) pre-incubated with either 9B4 or 21A5 MAb
at concentrations ranging from 1x10-9 M to 7x10-9 M. Error bars
represent 95% CIs of mean value where indicated.
(TIF)
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